ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2023

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 59 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2023
NameSharesValueWeighting ↓
BNP PARIBAS FINANCIAL MARKETS 3$50.00%
OSAIC HOLDINGS, INC. 63,150$100,4090.00%
DIMENSIONAL FUND ADVISORS LP 184,122$292,7950.00%
Parallel Advisors, LLC 1,000$1,5900.00%
WELLS FARGO & COMPANY/MN 674$1,0720.00%
NORTHERN TRUST CORP 181,001$287,7920.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
LAZARD ASSET MANAGEMENT LLC 10,059$150.00%
GROUP ONE TRADING, L.P. 21,574$34,3030.00%
GEODE CAPITAL MANAGEMENT, LLC 887,046$1,410,4030.00%
STATE STREET CORP 281,854$448,1480.00%
MILLENNIUM MANAGEMENT LLC 112,326$178,5980.00%
DEUTSCHE BANK AG\ 18$290.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 36,413$57,8970.00%
WOLVERINE TRADING, LLC 13,258$21,0800.00%
BlackRock Inc. 1,403,611$2,231,7420.00%
Mariner, LLC 50,000$79,5000.00%
GHP Investment Advisors, Inc. 200$3780.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 56,300$89,5170.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 23,536$37,4220.00%
External links

This page lists ADVERUM BIOTECHNOLOGIES INC's shareholders in Q2 2023. To view ADVERUM BIOTECHNOLOGIES INC's shareholder history, click here.